PERNIX SLEEP INC. (SOMX)
Symbol Info
Listed Symbol SOMX
Name PERNIX SLEEP INC.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2011-12-31
Latest Fiscal Revenue $16,155,000
Latest Fiscal EPS $-10.16
Price Info
21 Day Moving Average $2.9462
21 Day EMA $2.975050
50 Day Moving Average $2.9836
50 Day EMA $2.896810
200 Day EMA $3.059580
200 Day Moving Average 2.393260
52 Week High $4.80
52 Week Low $1.29
52 Week Change $-31.818200
Alpha 0.036028
Beta 2.6058
Standard Deviation 0.435655
R2 0.106662
Periods 60
Share Information
10 Day Average Volume -
20 Day Average Volume 22,672
30 Day Average Volume 26,921
50 Day Average Volume 38,498
Outstanding Shares 7,203,843
Float Shares 7,203,843
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 26
Institute Holdings Date 2013-01-31
Institute Bought Previous 3 Months 1,728,063
Institute Holdings Percent 41.400000
Institute Sold Previous 3 Months 2,010,487
Insider Holdings Date 2013-01-31
Insider Bought Previous 3 Months 140,000
Insider Holdings Percent 2.40%
Insider Sold Previous 3 Months 412
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $0.1500001
21 Day Percent Change 5.26%
30 Day Price Change $0.0500000
30 Day Percent Change 1.69%
Month To Date Price Change $0.1600
Month To Date Percent 5.63%
90 Day Price Change $-0.07
90 Day Percent Change -2.28%
Quarter To Date $-0.05
Quarter To Date Percent -1.64%
180 Day Price Change $0.600000
180 Day Percent Change 25.00%
200 Day Price Change $0.600000
200 Day Percent Change 25.00%
Year To Date $-0.05
Year To Date Percent -1.64%
Profile
Description
Details
Issue Type CS
Market Cap $21,611,529
Sec Type EQS
Auditor PricewaterhouseCoopers LLP
Total Shares Outstanding -
CEO Richard W. Pascoe
Employees 36
Last Audit UE
Classification
CIK 0001339455
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 3570 Carmel Mountain Road
Suite 100
San Diego, CA 92130
Website www.somaxon.com
Facisimile ++ 858 509-1761
Telephone +1 858 876-6500
Email
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -149.9
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin 85.20
Profit Margin TOT -
Income Statements
Revenue $12,140,000
Revenue Per Share $1.6852
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $-
Price To Sales 1.780192
Price To Free Cash -1.4
PE High Last 5 Years -
Price To Book 7.7
Price To Cash Flow -1.1
PE Low Last 5 Years -
Price To Tangible Book 11.9
Financial Strength
Total Debt To Equity -
Int Coverage -1,268.8
Current Ratio 1.5
Leverage Ratio 2.9
Quick Ratio 1.3
Long Term Debt To Capital -
Assets
Receivables Turnover 7.5
Invoice Turnover 7.00
Assets Turnover 0.90
Management Effectiveness
Return Assets -162.4
Return On Equity -716.1
Return On Capital -716.1
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
SOMX
Somaxon
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.